Sanofi, Evotec team up for research on infectious diseases treatment

PARIS (Reuters) - Sanofi and Evotec said they had started exclusive talks over accelerating research into the treatment of infectious diseases, and added on Thursday that they would form a new open innovation platform in this area, led by Evotec.

U.S. judge says opioid settlement roadblocks may prompt trials

(Reuters) - A federal judge pushing for a settlement in lawsuits by state and local governments against drug companies over their roles in the U.S. opioid epidemic said on Wednesday that trials may be needed after both sides identified barriers to reaching a deal.

FDA's Gottlieb blames industry 'Kabuki drug pricing' for high costs

WASHINGTON (Reuters) - U.S. Food and Drug Administration chief, Scott Gottlieb, criticized pharmacy benefit managers, health insurers and drugmakers on Wednesday for "Kabuki drug-pricing constructs" that profit the industry at the expense of consumers.

Sanofi may seek U.S. approval for Dengvaxia despite Philippines outrage

PARIS (Reuters) - Sanofi will decide shortly whether to seek regulatory approval for its dengue vaccine Dengvaxia in the United States and remains committed to the medicine despite a health scare in the Philippines, a senior executive said on Wednesday.

Ukrainian doctor struggles with lack of resources

KIEV (Reuters) - Family doctor Dmitriy Rozumiy struggles to bridge the gap between what his patients in rural Ukraine need and what the country's cash-strapped healthcare system can provide.

Roche names Pao head of drugs research and early development

ZURICH (Reuters) - Swiss drugmaker Roche named U.S. cancer expert William Pao head of its Pharma Research and Early Development (pRED) business after John Reed decided to leave for what it called personal reasons.

Eisai clinches Merck deal to develop and sell cancer drug, shares soar

NEW YORK/TOKYO (Reuters) - Merck & Co Inc and Japan's Eisai Co Ltd have signed a potential multibillion-dollar collaboration to develop and sell Eisai's cancer drug Lenvima, which is already approved in dozens of countries for two uses.

U.S. sailors visit Vietnamese shelter for victims of Agent Orange

DANANG, Vietnam (Reuters) - Sailors from a U.S. aircraft carrier on Wednesday visited a Vietnamese shelter for people suffering from the effects of Agent Orange, a chemical used by the U.S. military during the Vietnam War to destroy foliage.

FDA receives new reports of issues with Essure birth control device

(Reuters) - The U.S. Food and Drug Administration is investigating new reports of Bayer's implanted birth control device Essure causing problems during removal, the agency said on Wednesday, two years after it slapped a warning label on the product.

Europe's medicines regulator calls for recall of Biogen, AbbVie multiple sclerosis drug

(Reuters) - Europe's medicines regulator recommended the immediate suspension and recall of Biogen Inc and AbbVie Inc's multiple sclerosis drug Zinbryta, following 12 reports of inflammation of the brain, three of which cases were fatal.

Related Videos

Whalecam reveals secrets of Antarctic minke

Hybrid bee at the heart of UAE sustainable honey plan

Read Reuters on the go

Download the free Reuters News app today for breaking news, analysis and market data from the world's most trusted news organization.

Get the app